-
Je něco špatně v tomto záznamu ?
SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers
M. Golshani, LM. Svobodová, L. Štěpánek, J. Zeman, P. Nytrová, H. Posová, P. Petrásková, O. Novotná, M. Nováková, V. Černý, J. Beneš, L. Kolářová, M. Vokurka, J. Hrdý
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-03-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
36560450
DOI
10.3390/vaccines10122038
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: COVID-19 pandemic has led to a loss of human life in millions and devastating socio-economic consequences worldwide. So far, vaccination is the most effective long-term strategy to control and prevent severe COVID-19 disease. The aim of the current study was to evaluate the humoral immune responses raised against the BNT162b2 vaccine in hospital healthcare workers. METHODS: Total number of 173 healthcare workers enrolled in the study. Their blood samples were collected in three different time intervals after the second SARS-CoV-2 vaccination and evaluated by the ELISA method to detect anti-spike protein IgM and IgG antibodies. The baseline characteristics of all participants were collected using questionnaires and were evaluated for finding any significant data. RESULTS: Our results demonstrated that the levels of antibodies were higher in the young group (21-30 years old) and also among male participants. Moreover, the highest levels of antibodies were detected from the group that received the third shot vaccination. CONCLUSIONS: Our results indicate that age, gender and third-dose vaccination can affect the levels of humoral immune responses against the BNT162b2 vaccine in healthcare workers.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22031176
- 003
- CZ-PrNML
- 005
- 20230704111946.0
- 007
- ta
- 008
- 230119s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/vaccines10122038 $2 doi
- 035 __
- $a (PubMed)36560450
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Golshani, Maryam $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000244246470
- 245 10
- $a SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers / $c M. Golshani, LM. Svobodová, L. Štěpánek, J. Zeman, P. Nytrová, H. Posová, P. Petrásková, O. Novotná, M. Nováková, V. Černý, J. Beneš, L. Kolářová, M. Vokurka, J. Hrdý
- 520 9_
- $a BACKGROUND: COVID-19 pandemic has led to a loss of human life in millions and devastating socio-economic consequences worldwide. So far, vaccination is the most effective long-term strategy to control and prevent severe COVID-19 disease. The aim of the current study was to evaluate the humoral immune responses raised against the BNT162b2 vaccine in hospital healthcare workers. METHODS: Total number of 173 healthcare workers enrolled in the study. Their blood samples were collected in three different time intervals after the second SARS-CoV-2 vaccination and evaluated by the ELISA method to detect anti-spike protein IgM and IgG antibodies. The baseline characteristics of all participants were collected using questionnaires and were evaluated for finding any significant data. RESULTS: Our results demonstrated that the levels of antibodies were higher in the young group (21-30 years old) and also among male participants. Moreover, the highest levels of antibodies were detected from the group that received the third shot vaccination. CONCLUSIONS: Our results indicate that age, gender and third-dose vaccination can affect the levels of humoral immune responses against the BNT162b2 vaccine in healthcare workers.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Svobodová, Ludmila Maffei $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Štěpánek, Lubomír $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Zeman, Jan $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Nytrová, Petra $u General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Posová, Helena $u General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Petrásková, Petra $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Novotná, Olga $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Nováková, Michaela $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Černý, Viktor, $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000283197827 $d 1985- $7 xx0303525
- 700 1_
- $a Beneš, Jiří $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Kolářová, Libuše $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Vokurka, Martin $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
- 700 1_
- $a Hrdý, Jiří $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000306124509
- 773 0_
- $w MED00200686 $t Vaccines $x 2076-393X $g Roč. 10, č. 12 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36560450 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230119 $b ABA008
- 991 __
- $a 20230704111943 $b ABA008
- 999 __
- $a ok $b bmc $g 1889400 $s 1182509
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2022 $b 10 $c 12 $e 20221129 $i 2076-393X $m Vaccines $n Vaccines (Basel) $x MED00200686
- LZP __
- $a Pubmed-20230119